Alkeus Pharmaceuticals
PHARMACEUTICAL
Ophthalmics
LocationMA - Cambridge
Employees1-50
Open Jobs6
Pipeline
ALK-001Phase 3
General Interest
Alkeus Pharmaceuticals
This listing was originally posted on Alkeus Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAlkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.
We are looking for enthusiastic professionals who want to be at the forefront of our mission and make a significant impact on the growth and direction of Alkeus Pharmaceuticals.
We invite you to apply and submit your resume for general consideration.
#LI-DNI
Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Alkeus Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Ophthalmics
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo